v3.25.4
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Net Unrealized (Losses) Gains on Investments [Member]
Foreign Currency Translation (Losses) Gains [Member]
Noncontrolling Interest
Balance at Dec. 31, 2022 $ 81,450 $ 9 $ 0 $ 86,156 $ (2,778) $ (5,615) $ 3,678
Balance (in shares) at Dec. 31, 2022   934          
Net earnings attributable to UnitedHealth Group common shareholders 22,381     22,381      
Net earnings attributable to nonredeemable noncontrolling interest             575
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 22,956            
Other comprehensive income (loss) 1,366       807 559  
Issuances of common stock, and related tax effects (in shares)   6          
Issuances of common stock, and related tax effects 1,231 $ 0 1,231        
Share-based compensation 1,027   1,027        
Common share repurchases (in shares)   (16)          
Common share repurchases (8,059) $ 0 (2,057) (6,002)      
Cash dividends paid on common shares ($8.73 per share, $8.18 per share, and $7.29 per share or the years ended December 31, 2025, 2024, and 2023, respectively) (6,761)     (6,761)      
Redeemable noncontrolling interests fair value and other adjustments (201)   (201)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 1,928           1,928
Distributions to nonredeemable noncontrolling interests (516)           (516)
Balance at Dec. 31, 2023 94,421 $ 9 0 95,774 (1,971) (5,056) 5,665
Balance (in shares) at Dec. 31, 2023   924          
Net earnings attributable to UnitedHealth Group common shareholders 14,405     14,405      
Net earnings attributable to nonredeemable noncontrolling interest             663
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 15,068            
Other comprehensive income (loss) 3,640       (255) 3,895  
Issuances of common stock, and related tax effects (in shares)   8          
Issuances of common stock, and related tax effects 1,485 $ 0 1,485        
Share-based compensation $ 963   963        
Common share repurchases (in shares) (17) (17)          
Common share repurchases $ (9,005) $ 0 (2,395) (6,610)      
Cash dividends paid on common shares ($8.73 per share, $8.18 per share, and $7.29 per share or the years ended December 31, 2025, 2024, and 2023, respectively) (7,533)     (7,533)      
Redeemable noncontrolling interests fair value and other adjustments (53)   (53)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 26           26
Distributions to nonredeemable noncontrolling interests (744)           (744)
Balance at Dec. 31, 2024 $ 98,268 $ 9 0 96,036 (2,226) (1,161) 5,610
Balance (in shares) at Dec. 31, 2024 915 915          
Net earnings attributable to UnitedHealth Group common shareholders $ 12,056     12,056      
Net earnings attributable to nonredeemable noncontrolling interest             677
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 12,733            
Other comprehensive income (loss) 1,326       1,148 178  
Issuances of common stock, and related tax effects (in shares)   3          
Issuances of common stock, and related tax effects 649 $ 0 649        
Share-based compensation $ 979   979        
Common share repurchases (in shares) (12) (12)          
Common share repurchases $ (5,525) $ 0 (952) (4,573)      
Cash dividends paid on common shares ($8.73 per share, $8.18 per share, and $7.29 per share or the years ended December 31, 2025, 2024, and 2023, respectively) (7,916)     (7,916)      
Redeemable noncontrolling interests fair value and other adjustments (117)   (117)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 390           390
Distributions to nonredeemable noncontrolling interests (697)           (697)
Balance at Dec. 31, 2025 $ 100,090 $ 9 $ 559 $ 95,603 $ (1,078) $ (983) $ 5,980
Balance (in shares) at Dec. 31, 2025 906 906